The Board found that the veteran's skin disorder of the scalp did not result from disease or injury incurred in or aggravated by active military service. The condition was noted prior to his entry into service and there was no evidence of a permanent worsening during his brief period of military service.
The deciding factor: The preexisting skin disorder of the scalp was not shown to have undergone a permanent worsening during the veteran's brief period of military service, and there is no clear and unmistakable evidence that it did so. The Board found that the veteran's claim for service connection must be denied as there is insufficient evidence to establish an in-service aggravation.
- Claimed conditions
- dissecting cellulitis, seborrheic dermatitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- December 11, 2002
- Citation
- 0217907
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0217907.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for service connection for alopecia areata or alopecia androgenic, pseudofolliculitis barbae, and seborrheic dermatitis due to a need for additional evidence.
- Partly granted
The Board granted a 10 percent disability rating for dermatitis, variously diagnosed as seborrheic dermatitis, dermatophytosis, and tinea versicolor, prior to June 5, 2023, but denied a higher rating from that date. The issues related to Raynaud's syndrome and special monthly compensation were remanded.
- Remanded (sent back)
The Board remands the matter for further development to ensure compliance with previous remand instructions, specifically regarding obtaining a medical opinion from an appropriate specialist and notifying the Veteran about the unavailability of his separation examination.
- Partly granted
The Board granted an initial 30 percent rating for migraine headaches prior to December 5, 2016, and a 50 percent rating from May 31, 2024. The claims for increased ratings for Raynaud's syndrome and seborrheic dermatitis were denied.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.